Near-term / Measurement & scope
Separate ACA evidence from other insurance systems
Keep employer-sponsored insurance, Medicare, Medicaid, and other product systems in separately documented analytical universes rather than treating one individual-market screen as a state health-care score.Source records1report custody
Linked markets1analytical context
Research themes2publication taxonomy
Evidence needs5future verification inputs
The source boundary stays visible from analysis to proposed action.
State Individual Insurance Concentration, 2024
Individual-insurance oversight should use the 2024 state concentration cross-section to prioritize disclosure and research, then connect structure to insurer identity, ownership, entry, plan design, networks, prices, quality, switching, and consumer outcomes before assigning cause or legal liability.
- Intended audience
- HHS, CMS, FTC, DOJ, Congress, state insurance regulators, state attorneys general, and competition researchers
- Policy priority
- Near-term
- Instrument
- Measurement & scope
- Publication
- AR-RB-2026-07 / version 1.0
- Canonical citation
- Antitrust Radar Research Team. (2026, July 24). State Individual Insurance Concentration, 2024: Highly concentrated readings appear in 36 of 51 jurisdictions. Competition Research Briefs, AR-RB-2026-07 (Version 1.0). Antitrust Radar. https://antitrustradar.org/reports/state-individual-insurance-concentration-2024
Inputs required to investigate the recommendation and its effects.
- 01State insurer identities, enrollment shares, and common control
- 02Stable plan, issuer, service-area, and jurisdiction identifiers
- 03Annual entry, exit, merger, exchange, ownership, and revision histories
- 04Premium, actuarial value, claims, denial, network, quality, and switching outcomes
- 05Separate product definitions and denominators across insurance systems